Indications
Zerbaxa is indicated for the treatment of the following infections in adults: Complicated intra abdominal infections; Acute pyelonephritis; Complicated urinary tract infections; Hospital-acquired pneumonia (HAP), including ventilator associated pneumonia (VAP). Consideration should be given to official guidance on the appropriate use of antibacterial agents.
Composition
- Active substance
- ceftolozane sulfate, tazobactam sodium
- International name (INN)
- ceftolozane;tazobactam
Official product information
The European public assessment report holds the summary of product characteristics and the package leaflet in every EU language.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Medicine
- Zerbaxa
- Active substance
- ceftolozane sulfate, tazobactam sodium
- ATC code
- J01DI54